Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl ... U.K. site dubbed “the Nucleus” with Cardinal Health serving as the U.S. commercial distribution partner.
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during ...
With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...